Variable | Collapse group (n = 44) | Survival group (n = 129) | p value |
---|---|---|---|
Age (years) | 43.3 ± 7.4 | 43.2 ± 8.7 | 0.965 |
Gender (male/female) | 38/6 | 112/17 | 0.938 |
Body mass index (kg/m2) | 24.5 ± 4.5 | 24 ± 3.7 | 0.512 |
Etiology | Â | Â | 0.312 |
 Alcohol abuse | 31 | 82 |  |
 Corticosteroid use | 8 | 19 |  |
 Idiopathic | 5 | 28 |  |
Ficat classification | Â | Â | 0.741 |
 Stage I | 4 | 14 |  |
 Stage IIA | 40 | 115 |  |
ARCO classification | Â | Â | < .001 |
 IA | 2 | 6 |  |
 IB | 2 | 7 |  |
 IC | 0 | 1 |  |
 IIA | 4 | 63 |  |
 IIB | 10 | 41 |  |
 IIC | 26 | 11 |  |
Symptom | Â | Â | < .001 |
 Acute onset of symptom | 14 | 23 |  |
 Asymptomatic | 24 | 79 |  |
 Delayed onset of symptom | 6 | 27 |  |
Necrotic location | Â | Â | < .001 |
 A | 1 | 22 |  |
 B | 3 | 45 |  |
 C1 | 15 | 51 |  |
 C2 | 25 | 11 |  |
Necrotic angle | Â | Â | < .001 |
 < 200° | 5 | 74 |  |
 200–249° | 10 | 36 |  |
 250–299° | 18 | 12 |  |
 > 299° | 11 | 7 |  |
BME before CD | Â | Â | < .001 |
 No | 29 | 116 |  |
 Yes | 15 | 13 |  |
Bone grafting (no. of hips) | Â | Â | 0.542 |
 No | 25 | 80 |  |
 Yes | 19 | 49 |  |
Triglyceride | 2.05 ± 1.16 | 1.95 ± 1.17 | 0.611 |
Total cholesterol | 4.50 ± 0.80 | 4.66 ± 0.92 | 0.305 |
White blood cell | 6.6 ± 2 | 6.7 ± 1.9 | 0.857 |
Hemoglobin | 138.0 ± 12.1 | 140.0 ± 16.8 | 0.493 |
Platelet | 188.8 ± 53.5 | 186.3 ± 49.9 | 0.787 |
Antithrombin III | 93 ± 11.9 | 92.5 ± 10.7 | 0.789 |